Impact Factor Journals
Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease.
Frontiers inPharmacology.
2022,
13,
876842,
ISSN: 1664-3224,
PDF.